Baseline Ex Vivo and Molecular Responses of Plasmodium falciparum Isolates to Piperaquine before Implementation of Dihydroartemisinin-Piperaquine in Senegal

Dihydroartemisinin-piperaquine, which was registered in 2017 in Senegal, is not currently used as the first-line treatment against uncomplicated malaria. A total of 6.6% to 17.1% of P. falciparum isolates collected in Dakar in 2013 to 2015 showed ex vivo-reduced susceptibility to piperaquine. Neithe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Robert, Marie Gladys, Foguim Tsombeng, Francis, Gendrot, Mathieu, Diawara, Silman, Madamet, Marylin, Kounta, Mame Bou, Wade, Khalifa Ababacar, Fall, Mansour, Gueye, Mamadou Wague, Benoit, Nicolas, Nakoulima, Aminata, Bercion, Raymond, Amalvict, Rémy, Fall, Bécaye, Wade, Boubacar, Diatta, Bakary, Pradines, Bruno
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2019
Teme:
Epidemiology and Surveillance
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496083/
https://ncbi.nlm.nih.gov/pubmed/30782997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02445-18
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki